Patents by Inventor Farida Sarangi

Farida Sarangi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210198633
    Abstract: Methods and compositions are provided for producing PDX1+/NKX6-1+ pancreatic progenitor cells from a PDX1+ endodermal cell population. The method comprises contacting the endodermal cell population with an EGF component and tankyrase inhibitor that binds to an adenosine subsite of a tankyrase enzyme, to induce the differentiation of at least a portion of the PDX1+ endodermal cell population into PDX1+NKX6-1+ pancreatic progenitor cells.
    Type: Application
    Filed: May 30, 2019
    Publication date: July 1, 2021
    Inventors: Maria Cristina NOSTRO, Farida SARANGI, Roman KORYTNIKOV, Emily MCGAUGH, Frankie Hoi Chun POON
  • Publication number: 20190128885
    Abstract: There is described herein a method for enriching/purifying a population of cells for pancreatic progenitor cells, the method comprising: a) providing the population cells, the population comprising pancreatic progenitor cells; and b) performing at least one of steps (i)-(v): (i) selecting for cells from the population that express at least one protein listed in cluster 2; (ii) selecting for cells from the population that express at least one protein listed in cluster 5; (iii) deselecting for cells from the population that express at least one protein listed in cluster 1; (iv) deselecting for cells from the population that express at least one protein listed in cluster 3; and (v) deselecting for cells from the population that express at least one protein listed in cluster 6.
    Type: Application
    Filed: July 24, 2018
    Publication date: May 2, 2019
    Inventors: Maria Cristina NOSTRO, Thomas KISLINGER, Kathryn COGGER, Ankit SINHA, Farida SARANGI
  • Publication number: 20150104430
    Abstract: Methods and compositions for producing NKX6-1+ pancreatic progenitor cells and/or insulin producing cells from an endodermal cell population, the method comprising contacting the endodermal cell population with an EGF component, a Nicotinamide component and/or a Noggin component, optionally a combination of at least one EGF component and at least one nicotinamide component to induce the differentiation of at least one endodermal cell into a NKX6-1+ pancreatic progenitor cell, the combination optionally further comprising at least one Noggin component.
    Type: Application
    Filed: April 30, 2013
    Publication date: April 16, 2015
    Applicant: University Health Network
    Inventors: Gordon Keller, Maria Cristina Nostro, Audrey Holtzinger, Farida Sarangi